应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01099 国药控股
休市中 01-02 16:08:46
19.730
+0.290
+1.49%
最高
19.730
最低
19.310
成交量
171.87万
今开
19.440
昨收
19.440
日振幅
2.16%
总市值
615.77亿
流通市值
264.74亿
总股本
31.21亿
成交额
3,373万
换手率
0.13%
流通股本
13.42亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 国药控股 01月02日卖空量成交10万股,卖空比例为5.82%
市场透视 · 01-02 16:30
每日卖空追踪 | 国药控股 01月02日卖空量成交10万股,卖空比例为5.82%
第4次“圈地运动”!国药再砸122亿,上药、华润扩“内需”,流通巨头新活法?
E药经理人 · 12-31 18:18
第4次“圈地运动”!国药再砸122亿,上药、华润扩“内需”,流通巨头新活法?
每日卖空追踪 | 国药控股 12月31日卖空量成交70.32万股,卖空比例为17.64%
市场透视 · 12-31 16:30
每日卖空追踪 | 国药控股 12月31日卖空量成交70.32万股,卖空比例为17.64%
每日卖空追踪 | 国药控股 12月30日卖空量成交66.64万股,卖空比例为17.05%
市场透视 · 2025-12-30
每日卖空追踪 | 国药控股 12月30日卖空量成交66.64万股,卖空比例为17.05%
每日卖空追踪 | 国药控股 12月24日卖空量成交26.92万股,卖空比例为19.89%
市场透视 · 2025-12-24
每日卖空追踪 | 国药控股 12月24日卖空量成交26.92万股,卖空比例为19.89%
国药控股12月23日获主力加仓465.9万元
市场透视 · 2025-12-23
国药控股12月23日获主力加仓465.9万元
国药控股完成高层更迭晋斌正式出任董事长;先声药业与益普生达成10.6亿美元授权合作;德达博妥单抗新适应症申报上市
药财社 · 2025-12-22
国药控股完成高层更迭晋斌正式出任董事长;先声药业与益普生达成10.6亿美元授权合作;德达博妥单抗新适应症申报上市
每日卖空追踪 | 国药控股 12月22日卖空量成交18.08万股,卖空比例为5.03%
市场透视 · 2025-12-22
每日卖空追踪 | 国药控股 12月22日卖空量成交18.08万股,卖空比例为5.03%
国药控股,新董事长上任!
IVD资讯 · 2025-12-21
国药控股,新董事长上任!
刚刚!国药控股董事长正式官宣
赛柏蓝 · 2025-12-19
刚刚!国药控股董事长正式官宣
每日卖空追踪 | 国药控股 12月19日卖空量成交23万股,卖空比例为6.63%
市场透视 · 2025-12-19
每日卖空追踪 | 国药控股 12月19日卖空量成交23万股,卖空比例为6.63%
【券商聚焦】交银国际:临近年末 续看好新BD交易集中落地机会
金吾财讯 · 2025-12-19
【券商聚焦】交银国际:临近年末 续看好新BD交易集中落地机会
每日卖空追踪 | 国药控股 12月18日卖空量成交25.28万股,卖空比例为7.03%
市场透视 · 2025-12-18
每日卖空追踪 | 国药控股 12月18日卖空量成交25.28万股,卖空比例为7.03%
国药控股12月17日获主力加仓141.5万元
市场透视 · 2025-12-17
国药控股12月17日获主力加仓141.5万元
每日卖空追踪 | 国药控股 12月16日卖空量成交34.32万股,卖空比例为11.39%
市场透视 · 2025-12-16
每日卖空追踪 | 国药控股 12月16日卖空量成交34.32万股,卖空比例为11.39%
国药控股12月09日主力净流出163.0万元 散户资金买入
市场透视 · 2025-12-09
国药控股12月09日主力净流出163.0万元 散户资金买入
每日卖空追踪 | 国药控股 12月08日卖空量成交7.28万股,卖空比例为3.3%
市场透视 · 2025-12-08
每日卖空追踪 | 国药控股 12月08日卖空量成交7.28万股,卖空比例为3.3%
【券商聚焦】交银国际:医药行业短期催化剂充足 长期继续看好创新主线
金吾财讯 · 2025-12-05
【券商聚焦】交银国际:医药行业短期催化剂充足 长期继续看好创新主线
122亿!国药控股大合作来了
赛柏蓝 · 2025-12-04
122亿!国药控股大合作来了
国药控股(01099)更新2025年11月股份变动月报表,股本维持不变
公告速递 · 2025-12-04
国药控股(01099)更新2025年11月股份变动月报表,股本维持不变
加载更多
公司概况
公司名称:
国药控股
所属市场:
SEHK
上市日期:
--
主营业务:
国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。
发行价格:
--
{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":19.73,"timestamp":1767341326003,"preClose":19.44,"halted":0,"volume":1718713,"delay":0,"floatShares":1341810740,"shares":3121000000,"eps":2.524703777524973,"marketStatus":"休市中","change":0.29,"latestTime":"01-02 16:08:46","open":19.44,"high":19.73,"low":19.31,"amount":33731216,"amplitude":0.021605,"askPrice":19.73,"askSize":12800,"bidPrice":19.72,"bidSize":4800,"shortable":3,"etf":0,"ttmEps":2.5358905207343105,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":7,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":19.44,"dividendRate":0.037461,"openAndCloseTimeList":[[1767317400000,1767326400000],[1767330000000,1767340800000]],"volumeRatio":0.3347775787514966,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2192,"impliedVolPercentile":0.0935},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2600205063","title":"每日卖空追踪 | 国药控股 01月02日卖空量成交10万股,卖空比例为5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600205063","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600205063?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342619,"startTime":"0","endTime":"0","summary":"国药控股北京时间01月02日,涨1.49%,卖空量成交10万股,较上一交易日减少85.78%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163154a4942b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163154a4942b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","LU0640798160.USD","BK1500","BK1515","BK1197","01099"],"gpt_icon":0},{"id":"2595772344","title":"第4次“圈地运动”!国药再砸122亿,上药、华润扩“内需”,流通巨头新活法?","url":"https://stock-news.laohu8.com/highlight/detail?id=2595772344","media":"E药经理人","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595772344?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:18","pubTimestamp":1767176329,"startTime":"0","endTime":"0","summary":"2025年,四大“巨无霸”一边对外并购,一边对内整合。据商务部最新报告,2024年前五大流通“巨无霸”收入加起来约为13363亿元,同比增长仅0.6%,2023年同比增长为9.6%。国药今年先后完成两笔重要交易。荐阅读* 国药再下滑、九州通猛追,上药、华润守位,流通巨头业绩PK中的冲刺与对垒…*国药、上药、华润、九州通,5家千亿巨头就位!今年8月,华润医药商业增资浙江震元全资子公司震元医药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231185024a48e4dea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231185024a48e4dea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU1115378108.SGD","LU0640798160.USD","BK1500","BK1197","09939","01099","BK1574","BK1161","02607"],"gpt_icon":0},{"id":"2600705768","title":"每日卖空追踪 | 国药控股 12月31日卖空量成交70.32万股,卖空比例为17.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600705768","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600705768?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169818,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月31日,涨0.05%,卖空量成交70.32万股,较上一交易日减少43.25%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163235a48dc557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163235a48dc557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","01099","BK1500","BK1197","BK1515","LU0640798160.USD"],"gpt_icon":0},{"id":"2595719572","title":"每日卖空追踪 | 国药控股 12月30日卖空量成交66.64万股,卖空比例为17.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595719572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595719572?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083417,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月30日,跌0.36%,卖空量成交66.64万股,较上一交易日减少59.17%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163210a4897c4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163210a4897c4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","LU0640798160.USD","BK1197","LU1115378108.SGD","BK1515","01099"],"gpt_icon":0},{"id":"2593571403","title":"每日卖空追踪 | 国药控股 12月24日卖空量成交26.92万股,卖空比例为19.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593571403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593571403?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565017,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月24日,跌0.81%,卖空量成交26.92万股,较上一交易日减少72.45%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163225a4727daa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163225a4727daa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","LU1115378108.SGD","BK1197","BK1500","01099","BK1515"],"gpt_icon":0},{"id":"2593415534","title":"国药控股12月23日获主力加仓465.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593415534","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593415534?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477743,"startTime":"0","endTime":"0","summary":"12月23日, 国药控股股价涨0.31%,报收19.69元,成交金额7607.0万元,换手率0.29%,振幅1.32%,量比1.05。国药控股今日主力资金净流入465.9万元,上一交易日主力净流入208.7万元。该股近5个交易日上涨0.77%,主力资金累计净流入903.9万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3752.6万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161928a46e05df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161928a46e05df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","01099","BK1515","BK1500","LU0640798160.USD","LU1115378108.SGD"],"gpt_icon":0},{"id":"2593432075","title":"国药控股完成高层更迭晋斌正式出任董事长;先声药业与益普生达成10.6亿美元授权合作;德达博妥单抗新适应症申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2593432075","media":"药财社","labels":["executive","corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593432075?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:01","pubTimestamp":1766401284,"startTime":"0","endTime":"0","summary":"2先声药业与益普生达成10.6亿美元授权合作12月22日,先声药业宣布,本集团附属公司江苏先声再明医药有限公司于2025年12月19日与Ipsen Pharma签订独家授权许可协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222204937a6c18c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222204937a6c18c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","01099","BK1515","LU0640798160.USD","BK1583","BK1500","BK1197","LU1115378108.SGD"],"gpt_icon":0},{"id":"2593945224","title":"每日卖空追踪 | 国药控股 12月22日卖空量成交18.08万股,卖空比例为5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593945224","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593945224?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392218,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月22日,跌1.11%,卖空量成交18.08万股,较上一交易日减少80%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163329a46993ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163329a46993ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","01099","BK1515","BK1500","LU0640798160.USD","LU1115378108.SGD"],"gpt_icon":0},{"id":"2593714761","title":"国药控股,新董事长上任!","url":"https://stock-news.laohu8.com/highlight/detail?id=2593714761","media":"IVD资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593714761?lang=zh_cn&edition=full","pubTime":"2025-12-21 10:07","pubTimestamp":1766282866,"startTime":"0","endTime":"0","summary":"IVD资讯整理自国药控股12月19日,国药控股股东特别大会召开,官宣国药控股此前提名的国药系老将晋斌正式出任董事长。此前11月28日,国药控股发布公告,赵炳祥已向董事会提出辞任非执行董事、董事会董事长、董事会提名委员会主席、董事会战略与投资委员会主席、董事会法律合规与环境、社会及治理委员会委员及公司授权代表职务。晋先生自 2022年11月起担任国药集团副总经理,并自 2025年4月起兼任国药集团总法律顾问、首席合规官。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221102516a6bc1e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221102516a6bc1e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0640798160.USD","BK1197","LU1115378108.SGD","01099","BK1500"],"gpt_icon":0},{"id":"2592193511","title":"刚刚!国药控股董事长正式官宣","url":"https://stock-news.laohu8.com/highlight/detail?id=2592193511","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592193511?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:16","pubTimestamp":1766146608,"startTime":"0","endTime":"0","summary":"01国药控股换帅落定同步更新董事名单12月19日,随着国药控股股东特别大会的召开,国药控股此前提名的国药系老将晋斌正式出任董事长。回溯此次人事变动,11月28日,国药控股发布公告披露,原董事长赵炳祥因工作安排辞任,同时卸任非执行董事、董事会提名委员会主席、战略与投资委员会主席等多项职务。目前,国药控股最新董事名单已同步更新,具体角色与职能如下。强强合作成为国药控股扭转营收颓势的方式之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219205930a6b7466d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219205930a6b7466d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","LU1115378108.SGD","LU0640798160.USD","BK1515","01099","BK1500"],"gpt_icon":0},{"id":"2592819357","title":"每日卖空追踪 | 国药控股 12月19日卖空量成交23万股,卖空比例为6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592819357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592819357?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133018,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月19日,涨0.3%,卖空量成交23万股,较上一交易日减少54.72%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163227a45f333d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163227a45f333d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","01099","LU1115378108.SGD","BK1197","BK1515","LU0640798160.USD"],"gpt_icon":0},{"id":"2592513686","title":"【券商聚焦】交银国际:临近年末 续看好新BD交易集中落地机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513686","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513686?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:20","pubTimestamp":1766107245,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报,本周多项超10亿美元的BD交易相继落地,合作伙伴既有MNC也有中小型生物科技公司。临近年末,该机构继续看好新BD交易集中落地机会。展望2026 年,该机构认为板块稳中向好态势延续,但影响市场表现的核心因素或呈分化态势,后续选股逻辑或将重回基本面和估值,即关注存在基本面预期差、当前仍被低估的个股。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971853","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","HK0000165453.HKD","LU0417516738.SGD","LU1720050803.USD","02268","LU1251922891.USD","LU0348825331.USD","BK1583","02228","LU2476274308.USD","BK1191","02367","LU0588546209.SGD","LU0417516902.SGD","LU1794554557.SGD","LU2399975544.HKD","09926","03933","LU2778985437.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","BK1500","LU1115378108.SGD","02196","LU0634319403.HKD","LU0348783233.USD","BK1588","BK1585","LU0348784397.USD","LU2328871848.SGD","LU0348735423.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU1770034418.SGD","01530","LU0307460666.USD","BK1593","BK1197","01099","01789","06160","BK1147","BK1617","LU0348766576.USD","LU1303224171.USD","LU2476274720.SGD","LU0561508036.HKD","03329","09688","SG9999014674.SGD"],"gpt_icon":0},{"id":"2592372321","title":"每日卖空追踪 | 国药控股 12月18日卖空量成交25.28万股,卖空比例为7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592372321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592372321?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046617,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月18日,涨0.87%,卖空量成交25.28万股,较上一交易日减少61.88%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163213a45a9fe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163213a45a9fe3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01099","BK1515","BK1500","LU1115378108.SGD","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"2592794618","title":"国药控股12月17日获主力加仓141.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592794618","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592794618?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:16","pubTimestamp":1765959367,"startTime":"0","endTime":"0","summary":"12月17日, 国药控股股价涨0.36%,报收19.62元,成交金额5917.2万元,换手率0.23%,振幅1.28%,量比0.85。国药控股今日主力资金净流入141.5万元,连续4日净流入,上一交易日主力净流入148.7万元。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为37.50%,平均涨幅为0.73%。该股近5个交易日下跌1.00%,主力资金累计净流入1786.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入4366.6万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162345a6ad18dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162345a6ad18dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1500","LU0640798160.USD","BK1197","01099","LU1115378108.SGD"],"gpt_icon":0},{"id":"2592959085","title":"每日卖空追踪 | 国药控股 12月16日卖空量成交34.32万股,卖空比例为11.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592959085","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592959085?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873817,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月16日,跌2.05%,卖空量成交34.32万股,较上一交易日减少73.74%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163241a6a8b478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163241a6a8b478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU1115378108.SGD","LU0640798160.USD","BK1500","BK1197","01099"],"gpt_icon":0},{"id":"2590315093","title":"国药控股12月09日主力净流出163.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590315093","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590315093?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:15","pubTimestamp":1765268126,"startTime":"0","endTime":"0","summary":"12月09日, 国药控股股价跌1.57%,报收20.04元,成交金额7110.0万元,换手率0.26%,振幅2.55%,量比0.97。国药控股今日主力资金净流出163.0万元,上一交易日主力净流入70.9万元。该股近5个交易日上涨0.49%,主力资金累计净流入2.3万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入7394.9万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209161706a72ce74a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209161706a72ce74a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","01099","BK1515","BK1500","LU1115378108.SGD","LU0640798160.USD"],"gpt_icon":0},{"id":"2590350477","title":"每日卖空追踪 | 国药控股 12月08日卖空量成交7.28万股,卖空比例为3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590350477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590350477?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182617,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月08日,跌0.97%,卖空量成交7.28万股,较上一交易日减少94.24%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163228a72aae2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163228a72aae2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","BK1515","BK1500","01099"],"gpt_icon":0},{"id":"2589402852","title":"【券商聚焦】交银国际:医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,2025年10月以来,内资通过港股通持有医药股的比例小幅下降,外资持仓从年中起亦呈回落态势,但内外资加大创新药布局的大方向不变。而外资则更积极,聚焦创新主线中的龙头及产业链上游,包括恒瑞医药、君实生物和荣昌生物等创新药,及康龙化成、药明康德和泰格医药等CXO标的。12月,行业仍有充足催化剂,包括各项学术大会、医保谈判结果公布、美联储潜在降息等,板块投资情绪有望稳中有升。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0540923850.HKD","LU0417516738.SGD","LU2778985437.USD","BK1588","03933","09926","01789","BK1147","LU2328871848.SGD","BK1141","02228","LU1770034418.SGD","SG9999004311.SGD","02367","BK1197","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348827113.USD","LU0640798160.USD","LU2476274308.USD","LU0417516902.SGD","01099","BK1500","LU1251922891.USD","03329","06160","LU2399975544.HKD","09688","LU0561508036.HKD","LU0634319403.HKD","LU0348825331.USD","BK1585","LU1969619763.USD","SG9999014674.SGD","LU0417516571.SGD","LU1303224171.USD","BK1583","LU0348766576.USD","02196","BK1617","BK1593","LU2488822045.USD","BK1161","02268","LU1794554557.SGD","LU2476274720.SGD","01530","LU0588546209.SGD","HK0000165453.HKD"],"gpt_icon":1},{"id":"2589834810","title":"122亿!国药控股大合作来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834810","media":"赛柏蓝","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589834810?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:33","pubTimestamp":1764844407,"startTime":"0","endTime":"0","summary":"01国药控股再次牵手复宏汉霖12月3日,复宏汉霖消息称,将重续与国药控股经销合作,合作期限为2026年1月1日至2028年12月31日。2023年-2025年9月,国药控股分别完成了19.17亿元、20.40亿元以及16.93亿元的销售额。在此背景下,国药控股与复宏汉霖再次达成合作,未来三年的产品销售总额上限高达122.24亿元。12月2日,国药控股官方微信消息称,近日与皮尔法伯制药进行了战略合作签约。在2025年上半年时,国药控股营收和归母净利润较同期分别下降2.95%和6.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204204517a723d0b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204204517a723d0b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01099","BK1515","LU0640798160.USD","HK0000165453.HKD","BK1197","LU1115378108.SGD","02696","BK1500"],"gpt_icon":0},{"id":"1131409240","title":"国药控股(01099)更新2025年11月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1131409240","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131409240?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:58","pubTimestamp":1764838731,"startTime":"0","endTime":"0","summary":"国药控股股份有限公司(01099)于2025年12月4日递交2025年11月股份变动月报表。公告显示,截至报告期末(2025年11月30日),公司H股和内资股的已发行及注册股本均无增减变动,股本结构维持不变。\n具体来看,H股于本月末保持1,341,810,740股,内资股于本月末保持1,778,845,451股,总股本规模为人民币3,120,656,191元。公告中提及的股份期权、可换股票据等方面均无新增或变动事项,当月未发生任何购回或注销活动。\n公司在公告中表示将继续遵守香港联交所《上市规则》及相关法律法规,此次月报表由公司秘书吴壹建签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":-0.0319},{"period":"3month","weight":0.0562},{"period":"6month","weight":0.0653},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":0.0149}],"compareEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0224},{"period":"3month","weight":-0.0296},{"period":"6month","weight":0.1013},{"period":"1year","weight":0.3422},{"period":"ytd","weight":0.0276}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.001163},{"month":2,"riseRate":0.5625,"avgChangeRate":0.030473},{"month":3,"riseRate":0.5,"avgChangeRate":0.010225},{"month":4,"riseRate":0.4375,"avgChangeRate":0.022869},{"month":5,"riseRate":0.625,"avgChangeRate":-0.004548},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.011177},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042295},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.007287},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004122}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}